Ignite Creation Date:
2024-05-06 @ 2:49 PM
Last Modification Date:
2024-10-26 @ 1:37 PM
Study NCT ID:
NCT04432155
Status:
UNKNOWN
Last Update Posted:
2021-03-03
First Post:
2020-06-11
Brief Title:
Xenon Inhalation for Treatment of Panic Disorder
Sponsor:
Nobilis Therapeutics Inc
Organization:
Nobilis Therapeutics Inc
Study Overview
Official Title:
A Double-Blind Randomized Placebo-Controlled Trial of Xenon Inhalation for Treatment of Patients With Panic Disorder
Status:
UNKNOWN
Status Verified Date:
2021-03
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a double-blind randomized placebo-controlled clinical trial in parallel groups in patients with panic disorder
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None